DATAR CANCER GENETICS PRIVATE LIMITED – Trademark Portfolio
Entity Type: 16
DATAR CANCER GENETICS PRIVATE LIMITED holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 5 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 5 trademarks are registered. Notable registered marks include CELLDX, TRINETRA, CANCERTRACK, PHOENIXZA DX, and GENEMASTER DX. The owner is based in Ambad Nashik.
F-8, D-Road
Ambad Nashik 422010 , IN
Showing of trademarks Trademarks
Trademark Classifications
DATAR CANCER GENETICS PRIVATE LIMITED's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does DATAR CANCER GENETICS PRIVATE LIMITED have?
DATAR CANCER GENETICS PRIVATE LIMITED has 5 U.S. trademarks filed with the USPTO. Of these, 5 registered.
What trademark classes does DATAR CANCER GENETICS PRIVATE LIMITED file in?
DATAR CANCER GENETICS PRIVATE LIMITED files trademarks across 2 Nice Classification classes. The most active classes are Class 44 (Medical Services), Class 42 (Computer & Scientific). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.
What are DATAR CANCER GENETICS PRIVATE LIMITED's most well-known trademarks?
DATAR CANCER GENETICS PRIVATE LIMITED's registered trademark portfolio includes well-known marks such as CELLDX, TRINETRA, CANCERTRACK, PHOENIXZA DX, and GENEMASTER DX. These are among 5 currently registered trademarks in the portfolio.
What is DATAR CANCER GENETICS PRIVATE LIMITED's trademark registration success rate?
DATAR CANCER GENETICS PRIVATE LIMITED has a 100% trademark registration rate, with 5 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.